Riskpilot← Back to searchSign inGet full accessBIOTECH-IGG ApS
APSBankruptCVR 32099807Arne Jacobsens Allé 7, 5.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20092 employees
Revenue 2017
DKK -102K
-156% vs 2016
EBITDA margin
540.3%
-3213% vs 2016
Equity ratio
42.3%
Financial strength
Net profit 2017
DKK -556K
-4496% vs 2016
| Revenue | DKK -102K | -156% |
| EBITDA | DKK -551K | -3213% |
| Net profit | DKK -556K | -4496% |
| Total assets | DKK 1,5M | -4% |
| Equity | DKK 634K | -47% |
| Employees | 2 | — |
Legal name
BIOTECH-IGG ApS
CVR number
32099807
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
16. april 2009
Share capital
DKK 500.000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2017-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Arne Jacobsens Allé 7, 5.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 361 | 285 | 897 | 428 | 181 | -102 |
| Staff expenses | -605 | -671 | -455 | -237 | -198 | -449 |
| EBITDA | -244 | -386 | 442 | 191 | -17 | -551 |
| Depreciation & amort. | 165 | -58 | -15 | -0 | -0 | -0 |
| EBIT | -409 | -445 | 428 | 191 | -17 | -551 |
| Net financials | 38 | -28 | -40 | -49 | 29 | -5 |
| Profit before tax | -371 | -473 | 388 | 141 | 13 | -556 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -371 | -473 | 388 | 141 | 13 | -556 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Total assets | 1.154 | 1.449 | 1.757 | 1.531 | 1.555 | 1.499 |
| Equity | 693 | 221 | 1.036 | 1.178 | 1.190 | 634 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 461 | 1.229 | 720 | 354 | 365 | 866 |
| Total debt | 461 | 1.229 | 720 | 354 | 365 | 866 |
EBITDA margin
-55124200.0%
This company
15.8%
Market median
-348887442% vs market
20122017
Equity ratio
42.3%
This company
38.2%
Market median
+11% vs market
20122017
Return on equity
-87.8%
This company
18.4%
Market median
-577% vs market
20122017
Net profit margin
-55649400.0%
This company
8.1%
Market median
-687029730% vs market
20122017
Asset turnover
-0.07×
This company
1.12×
Market median
-106% vs market
20122017
Debt / equity
1.37×
This company
0.62×
Market median
-121% vs market
20122017
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AE Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
AJ Management | Management | 2009 | — | — |
JK | Deputy | 2017 | — | — |
MC Unofficial title | Unofficial title | 2021 | — | — |
KA Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2009 | |
| Individual | 100.0% | 100.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BIOTECH-IGG ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Edvardsson | Chief Executive Officer | 0 companies |
| Alistair John Hurst | Management | 0 companies |
| Johan Karl-Herbert Backman | Deputy | 0 companies |
| Michael Christian Torben Serring | Unofficial title | 0 companies |
| Kirstin Ann Kriz | Management | 0 companies |
| Edvard Skodic | Board of Directors | 0 companies |
| Lars Olof Artur Hansson | Board of Directors | 0 companies |
| Mats Åke Andersson | Chairman | 0 companies |
| Margaret Anne Hurst | Board of Directors | 0 companies |
| Margareta Anna Kriz | Board of Directors | 0 companies |
| Georg Aram Soma | Board of Directors | 0 companies |
| Anders Simon Ulric Aspegrén | Board of Directors | 0 companies |
| Margareta Krook | Board of Directors | 0 companies |
| Faridoon Qazi | Board of Directors | 0 companies |
| Stefan Bo Erik Nyman | Board of Directors | 0 companies |